HYO

[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate

Created:	2020-01-02
Last modified:	2020-03-18

Find Related PDB Entry
6 entries where HYO is found as a standalone ligand

Help Find related ligands:
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Help

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	4
Bond Count	46
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate
Systematic Name (OpenEye OEToolkits)	[(1~{R},5~{S})-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2~{S})-3-oxidanyl-2-phenyl-propanoate
Formula	C₁₇ H₂₃ N O₃
Molecular Weight	289.369
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CN1[CH]2CC[CH]1C[CH](C2)OC(=O)[CH](CO)c3ccccc3
SMILES	OpenEye OEToolkits	2.0.7	CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3
Canonical SMILES	CACTVS	3.385	CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3
Canonical SMILES	OpenEye OEToolkits	2.0.7	CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)c3ccccc3
InChI	InChI	1.03	InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16-/m1/s1
InChIKey	InChI	1.03	RKUNBYITZUJHSG-FXUDXRNXSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00424
Name	Hyoscyamine
Groups	approved
Description	Hyoscyamine is a tropane alkaloid and the levo-isomer of [atropine].[A228423] It is commonly extracted from plants in the _Solanaceae_ or nightshade family.[A228423] Research into the action of hyoscyamine in published literature dates back to 1826.[A228713] Hyoscyamine is used for a wide variety of treatments and therapeutics due to its antimuscarinic properties.[L31548,L31553] Although hyoscyamine is marketed in the United States, it is not FDA approved.[L31548,L31553]
Synonyms	Daturin L-Hyoscyamine [3(S)-endo]-α-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester L-Tropine tropate (S)-atropine Hyoscyamin (S)-(−)-hyoscyamine Tropine-L-tropate Hyoscyamine sulfate Hyoscyaminum Daturine Hyoscyamine sulfate dihydrate Hyoscyamine (−)-hyoscyamine Hyoscyamine hydrobromide Duboisine (−)-atropine
Brand Names	Phosphasal B-Donna Urolet Mb Hyoscyamine Sulfate Sl Re-PB Hyos Hyoscyamine Sulfate Extended-Release Urimar-T Uribel UrNeva Uro-458 Donnatal Elixir Hyoscyamine Sulfate TAB Azuphen Mb UroAv-81 Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide Calmitol Itching Relief Ont Hyoscyamine Sulfate ODT UroAv-B Hyosyne Symax SR Uretron D/S Urin D/S Hyoscyamine sulfate Phenobarbital with Belladonna Alkaloids - Grape Me-PB-Hyos UR N-C Urinary Antiseptic Phenobarbital with Belladonna Alkaloids Symax FasTab Me NaPhos MB Hyo 1 HyoMax-SR Phenazopyridine Hydrochloride, Hyoscyamine Hydrobromide, and Butabarbital Vitetal Phenohytro Ed-spaz Indiomin Mb Phosenamine Levsin SL Utira-C Uro-MP Uralgic Hyoscyamine sulfate Sublingual Symax Duotab Urophen Mb Anaspaz Belladonna Alkaloids with Phenobartbital Hyoscyamine Sulfate Donnatal Tab Pyrelle H.B. Uro-L Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide Levsin Drops 0.125mg/ml Donnagel Liq Servira Urised Ustell Methylphen Re-PB Hyos Elixir HyoMax Hyoscyamine S L Hyoscyamine SL Prosed/DS Vilamit MB Hyoscyamine ER Uro-BLUE Urelle Hyoscyamine Sulfate SL Belladonna Alkaloids with Phenobarbital Uramit Mb Vilevev MB HyoMax-FT Uribel Tabs Phenazopyridine Plus PB Hyos Se-donna Pb Hyos Uta Hyolev Mb Phenobarbital With Belladonna Alkaloids Uro-SP Hyoscyamine Levbid Donnatal Urogesic Blue Darpaz Hyoscyamine Sulfate Drops Quadrapax Urimar-T Caps HyoMax-SL Donnatal Extentabs Srt Phenobarbital with Belladonna Alkaloids - Mint Symax SL Hyoscyamine Sulfate Sublingual Levsin Oscimin Darcalma HyoMax-DT Diban Cap NuLev Hyophen Donnatal Extentabs
Indication	As a drug that is not FDA approved, hyscyamine has no official indications.[L31548,L31553] Intravenous hysocyamine has been used to reduce gastric motility, reduce pancreatic pain and secretions, to facilitate imaging of the gastrointestinal tract, treat anticholinesterase toxicity, treat certain cases of partial heart block, improve visualization of the kidneys, and for symptomatic relief of biliary and renal colic.[L31548] Intravenous hyoscyamine is also used pre-operatively to reduce secretions of the mouth and respiratory tract to facilitate intubation.[L31548] Oral hyoscyamine is used to treat functional intestinal disorders, for symptomatic relief of biliary and renal colic, and symptomatic relief of acute rhinitis.[L31553]
Categories	Adjuvants, Anesthesia Agents producing tachycardia Alimentary Tract and Metabolism Alkaloids Anti-Asthmatic Agents Antiarrhythmic agents Anticholinergic Agents Atropine Derivatives Autonomic Agents Aza Compounds Azabicyclo Compounds Belladonna Alkaloids Belladonna Alkaloids, Tertiary Amines Belladonna and Derivatives, Plain Bronchodilator Agents Cardiovascular Agents Central Nervous System Agents Cholinergic Agents Drugs for Functional Gastrointestinal Disorders Muscarinic Antagonists Mydriatics Neurotransmitter Agents Parasympatholytics Peripheral Nervous System Agents Potential QTc-Prolonging Agents QTc Prolonging Agents Respiratory System Agents Solanaceous Alkaloids Tropanes
ATC-Code	A03BA03 A03CB31
CAS number	101-31-5

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Muscarinic acetylcholine receptor M1	MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF...	unknown	antagonist
Muscarinic acetylcholine receptor M5	MEGDSYHNATTVNGTPVNHQPLERHRLWEVITIAAVTAVVSLITIVGNVL...	unknown	antagonist
Muscarinic acetylcholine receptor M2	MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV...	unknown	antagonist
Muscarinic acetylcholine receptor M3	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFS...	unknown	antagonist
Muscarinic acetylcholine receptor M4	MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGN...	unknown	antagonist
Adenylate cyclase type 1	MAGAPRGGGGGGGGAGEPGGAERAAGTSRRRGLRACDEEFACPELEALFR...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682